lactobacillu
speci
commens
bacteria
long
recogn
probiot
microb
gener
regard
safe
gra
human
consumpt
investig
use
l
gasseri
vaccin
vector
oral
immun
mucos
pathogen
recent
research
shown
immun
respons
differ
lactobacilli
vari
wide
depend
speci
subspeci
lactobacillu
studi
lactobacilli
seem
induc
oral
toler
other
induc
adapt
immun
respons
studi
character
system
mucos
immun
respons
wildtyp
genet
modifi
l
gasseri
l
gasseri
primarili
activ
addit
activ
homodim
expand
tolllik
receptor
tlr
activ
profil
l
gasseri
immunogen
vector
plasmid
contain
flic
gene
encod
bacteri
flagellin
introduc
result
strong
activ
treatment
human
myeloid
dendrit
cell
recombin
lactobacilli
express
flagellin
trigger
phenotyp
matur
releas
proinflammatori
cytokin
contrast
bacteri
treatment
also
result
statist
signific
increas
product
vivo
studi
establish
treatment
l
gasseri
led
diversif
bcell
popul
lamina
propria
murin
colon
furthermor
treatment
genet
modifi
l
gasseri
led
signific
decreas
percentag
colon
lymphocyt
taken
togeth
data
clarifi
interact
l
gasseri
host
immun
system
support
investig
vivo
immunogen
l
gasseri
express
flagellin
candid
vaccin
antigen
sever
speci
lactobacilli
investig
antigen
deliveri
vehicl
spectrum
infecti
agent
includ
helicobact
pylori
tetanu
enterotoxigen
escherichia
coli
sever
acut
respiratori
syndrom
sar
associ
coronaviru
rotaviru
brucella
aborti
human
papillomaviru
review
refer
despit
grow
evid
lactobacilli
use
vaccin
vector
increasingli
clear
differ
speci
even
subspeci
lactobacilli
interact
distinctli
host
immun
system
sever
studi
analyz
abil
variou
lactobacillu
speci
induc
dendrit
cell
dc
matur
cytokin
product
show
rang
outcom
appear
favor
toler
one
end
spectrum
immun
activ
also
clear
differ
abil
lactobacilli
speci
surviv
hostil
environ
upper
gastrointestin
gi
tract
colon
lower
gi
tract
function
genom
studi
greatli
improv
understand
characterist
much
less
known
molecular
genet
basi
host
immunomodul
lactobacillu
speci
one
strategi
develop
lactobacilli
vaccin
vector
screen
mani
speci
strain
use
vitro
vivo
techniqu
identifi
best
strain
particular
applic
altern
fulli
character
one
promis
candid
genet
modifi
candid
particular
applic
lactobacillu
gasseri
commens
lactic
acidproduc
bacterium
human
intestin
genit
tract
gra
gener
regard
safe
statu
organ
function
genom
l
gasseri
well
character
full
complement
tool
avail
genet
manipul
recent
studi
demonstr
promis
l
gasseri
vaccin
vector
wherebi
mice
fulli
protect
challeng
anthrax
immun
l
gasseri
express
anthrax
protect
antigen
given
nich
human
microbiom
wellstudi
genom
success
preliminari
vaccin
studi
l
gasseri
attract
candid
ration
design
oral
vaccin
vector
design
vaccin
vector
optim
effect
safeti
howev
interact
l
gasseri
host
immun
system
must
clarifi
present
studi
investig
greater
depth
vitro
immunogen
potenti
wildtyp
wt
recombin
l
gasseri
regard
tolllik
receptor
tlr
activ
dendrit
cell
activ
cytokin
induct
vivo
immunogen
potenti
regard
effector
cell
modul
colon
lamina
propria
also
genet
modifi
l
gasseri
express
intracellular
flagellin
evalu
mean
expand
tlr
activ
profil
vector
importantli
investig
whether
genet
modif
advers
affect
bacteriumhost
interact
term
persist
colon
antilactobacillu
immun
respons
dc
isol
cocultur
untest
human
blood
buffi
coat
n
obtain
american
red
cross
durham
nc
isol
myeloid
dendrit
cell
mdc
buffi
coat
centrifug
plasma
remov
cell
underlay
ficollplaqu
plu
ge
healthcar
piscataway
nj
centrifug
allow
lymphocyt
isol
markerassist
congen
screen
mac
dendrit
cell
isol
kit
miltenyi
biotec
auburn
ca
use
accord
manufactur
instruct
enrich
dendrit
cell
puriti
consist
greater
enrich
dc
plate
plate
round
bottom
polypropylen
concentr
dc
per
l
filter
human
peripher
blood
mononuclear
cell
hpbmc
medium
rpmi
fetal
bovin
serum
fb
sodium
pyruv
glutamax
invitrogen
dc
cultur
duplic
either
mrspb
nm
invivogen
ngml
rflic
invivogen
bacteri
cocultur
atcc
nck
flicp
bacteria
per
dc
wildtyp
lactobacilli
grown
mr
broth
recombin
bacteria
grown
mr
erythromycin
gml
bacteria
centrifug
wash
pb
suspend
hpbmc
medium
ad
dc
cultur
follow
h
incub
dc
centrifug
remov
antibodi
stain
isothiocyan
fitc
clone
biolegend
pe
clone
biolegend
antihuman
hladrallophycocyanin
apc
clone
bd
pharmingen
supernat
retain
cytokin
analysi
cytokin
multiplex
assay
dclactobacillu
cocultur
supernat
n
analyz
presenc
granulocytemacrophag
colonystimul
factor
gmcsf
gamma
interferon
tumor
necrosi
factor
alpha
gcsf
monocyt
chemoattract
protein
macrophag
inflammatori
protein
eotaxin
fibroblast
growth
factor
fgf
basic
plateletderiv
growth
factor
pdgf
rant
vascular
endotheli
growth
factor
vegf
bioplex
array
reader
luminex
xmap
technolog
bioplex
manag
softwar
version
biorad
concentr
calcul
rel
intens
report
tag
use
fiveparamet
logist
regress
algorithm
fit
sampl
data
standard
curv
gener
prism
graphpad
softwar
la
jolla
ca
standard
cytokin
detect
within
rang
lower
upper
limit
pgml
sampl
data
fall
within
rang
use
statist
analysi
mous
inocul
mice
hous
care
accord
associ
assess
laboratori
anim
care
standard
institut
anim
care
use
committe
guidelin
sixweekold
femal
balbc
mice
nci
raleigh
nc
use
studi
prepar
oral
inoculum
proper
dose
bacteria
suspend
pb
l
inoculum
per
mous
entir
bacteri
suspens
deposit
stomach
oral
gavag
isol
murin
colon
lymphocyt
mice
receiv
oral
bacteri
treatment
interv
day
fourth
day
h
primari
dose
mice
euthan
via
carbon
dioxid
inhal
thoracotomi
colon
harvest
place
petri
dish
contain
pb
mm
dithiothreitol
dtt
colon
open
longitudin
cut
section
stir
digest
medium
min
digest
medium
consist
rpmi
invitrogen
volvol
hepe
invitrogen
peni
flowcytometr
analysi
colon
lymphocyt
evalu
percentag
bcell
popul
freshli
isol
colon
lymphocyt
underw
fc
receptor
block
clone
bd
bioscienc
stain
clone
biolegend
blue
clone
biolegend
clone
biolegend
min
ice
cell
fix
min
paraformaldehyd
analyz
lsr
ii
flow
cytomet
facsdiva
softwar
bd
bioscienc
analyz
percentag
lymphocyt
cell
cultur
monensin
biolegend
h
wash
stain
clone
biolegend
clone
biolegend
presenc
fc
receptor
block
reagent
bd
bioscienc
cell
fix
permeabil
stain
buffer
set
ebiosci
san
diego
ca
subsequ
stain
clone
biolegend
clone
biolegend
analysi
perform
lsr
ii
flow
cytomet
facsdiva
softwar
bd
bioscienc
harvest
prepar
fecal
sampl
fecal
sampl
harvest
homogen
solut
goat
serum
min
sampl
centrifug
l
supernat
remov
store
downstream
enzymelink
immunosorb
assay
elisa
test
remain
slurri
vortex
sampl
taken
quantif
bacteri
popul
quantifi
dosag
bacteria
grown
duplic
overnight
anaerob
condit
rogosa
agar
contain
erythromycin
gml
colorimetr
elisa
murin
antibodi
detect
l
gasseri
strain
atcc
grown
liquid
mr
medium
overnight
cultur
grown
od
centrifug
resuspend
pb
one
hundr
l
bacteri
suspensionwel
ad
maxisorp
elisa
plate
nunc
rochest
ny
dri
overnight
follow
day
plate
wash
five
time
tween
wash
buffer
tap
remov
excess
liquid
plate
block
pb
wtvol
bovin
serum
albumin
wtvol
glucos
volvol
goat
serum
h
room
temperatur
fecal
serum
sampl
serial
dilut
pb
wtvol
bovin
serum
albumin
wtvol
glucos
dilut
buffer
l
dilut
ad
well
plate
incub
h
wash
five
time
wash
buffer
goat
antimous
igghrp
polyclon
thermo
fisher
scientif
dilut
dilut
buffer
secondari
detect
reagent
serum
igg
goat
antimous
igahrp
polyclon
bethyl
montgomeri
tx
dilut
dilut
buffer
detect
reagent
fecal
iga
one
hundr
l
dilut
secondari
antibodi
ad
well
allow
incub
h
room
temperatur
plate
wash
five
time
wash
buffer
develop
tmb
substrat
kpl
gaithersburg
md
accord
manufactur
instruct
necropsi
gastrointestin
cultur
mice
euthan
via
carbon
dioxid
inhal
thoracotomi
bacteri
persist
studi
mice
euthan
h
postinocul
primeboost
studi
mice
euthan
week
final
boost
small
intestin
larg
intestin
cecum
harvest
place
individu
ml
pb
gastrointestin
gi
segment
cut
fragment
homogen
shake
min
sampl
vortex
l
sampl
plate
rogosa
agar
erythromycin
gml
plate
grown
anaerob
condit
overnight
determin
bacteri
colon
statist
analysi
analysi
varianc
gener
linear
model
sa
cari
nc
use
compar
treatment
data
assay
duncan
multipl
rang
test
use
posttest
group
data
base
signific
differ
lactobacillu
primarili
activ
secondari
activ
although
mani
studi
shown
lactobacilli
activ
complet
tlr
activ
profil
lactobacillu
speci
unknown
therefor
determin
tlr
activ
profil
l
gasseri
atcc
tabl
tlrmediat
nfb
product
determin
use
seapsecret
pnifti
report
plasmid
transfect
cell
express
individu
human
heterodim
l
gasseri
strongli
activ
lesser
activ
alon
fig
signific
activ
note
similar
result
observ
hek
cell
treat
l
acidophilu
ncfm
data
shown
suggest
tlr
activ
profil
l
gasseri
specif
speci
rather
indic
gener
lactobacillu
profil
determin
whether
recombin
bacteria
transform
activ
due
addit
bacteri
cpg
motif
atcc
nck
flicp
evalu
whole
cell
cell
lysat
without
liposom
encapsul
regardless
prepar
activ
human
murin
type
b
pathway
could
demonstr
data
shown
addit
analysi
cpg
motif
l
gasseri
atcc
clone
manag
softwar
sci
cari
nc
show
low
frequenc
genom
cpg
linucleotid
associ
low
level
activ
result
conclud
neither
l
gasseri
genom
plasmid
backbon
use
studi
intrins
expand
tlr
activ
repertoir
l
gasseri
includ
addit
flic
l
gasseri
result
activ
addit
clearli
shown
simultan
activ
multipl
tolllik
receptor
lead
amplifi
downstream
innat
adapt
immun
respons
express
basolater
surfac
intestin
epitheli
cell
lamina
propria
dc
follicleassoci
epithelium
peyer
patch
mice
make
ubiquit
target
oral
deliv
adjuv
expand
tlr
activ
profil
l
gasseri
includ
transform
l
gasseri
express
plasmid
pflicp
encod
sequenc
flagellin
flic
typhimurium
fig
figur
show
cell
lysat
flictransform
l
gasseri
activ
addit
live
l
gasseri
induc
greater
tolllik
receptor
activ
dead
lactobacilli
other
demonstr
differ
immunogen
live
versu
kill
recombin
bacteria
test
whether
live
uvkil
lactobacilli
effici
activ
tolllik
receptor
whether
dosag
kill
bacteria
influenc
degre
tlr
activ
multipl
infect
moi
use
base
preliminari
titrat
studi
maximum
dose
live
bacteria
cytotox
cell
data
shown
dose
live
bacteria
compar
four
dose
kill
bacteria
cell
line
express
fig
dose
live
bacteria
alway
elicit
greater
nfb
respons
kill
bacteria
dose
kill
bacteria
statist
surpass
abil
live
bacteria
increas
nfb
product
system
live
bacteria
seem
greater
intrins
capac
activ
tlr
dead
bacteria
recombin
l
gasseri
induc
phenotyp
matur
human
myeloid
dc
establish
genet
modifi
lactobacilli
influenc
dendrit
cell
matur
coreceptor
express
mdc
surfac
express
major
histocompat
freshli
isol
human
mdc
puls
atcc
nck
flicp
trend
toward
increas
popul
mhcii
cell
respect
compar
untreat
control
mdc
fig
percentag
mhcii
cell
higher
two
mdc
group
puls
genet
modifi
l
gasseri
compar
untreat
control
mdc
popul
p
proport
mhcii
cell
mdc
puls
genet
modifi
l
gasseri
significantli
lower
mrstreat
control
mdc
popul
recombin
l
gasseri
induc
proinflammatori
cytokin
chemokin
releas
high
ratio
myeloid
dc
next
sought
determin
wildtyp
recombin
l
gasseri
strain
influenc
cytokin
chemokin
product
human
mdc
lactobacilli
incub
mdc
h
cultur
supernat
quantit
assay
cytokin
chemokin
level
gener
incub
l
gasseri
treatment
result
statist
signific
increas
proinflammatori
cytokin
product
dendrit
cell
includ
gmcsf
gcsf
fig
tabl
addit
lactobacilli
dc
also
result
statist
signific
increas
chemokin
secret
fig
tabl
final
l
gasseri
treatment
result
increas
product
compar
control
p
wherea
product
significantli
influenc
bacteri
treatment
fig
result
suggest
l
gasseri
role
promot
mix
cytokin
respons
dc
recruit
immun
cell
l
gasseri
treatment
lead
diversif
colon
bcell
popul
mice
recent
studi
shown
individu
probiot
bacteria
influenc
mucos
immun
respons
specif
immun
induct
site
murin
small
intestin
sought
determin
role
l
gasseri
gener
genet
modifi
lactobacilli
specif
colon
lamina
propria
effector
site
mucos
immun
system
want
determin
l
gasseri
express
flic
adjuv
would
influenc
plasma
cell
popul
chang
could
affect
downstream
antibodi
product
vaccin
deliveri
mice
oral
administ
cfu
bacteria
three
consecut
day
prior
euthanasia
upon
euthanasia
mononuclear
cell
isol
colon
tissu
stain
identifi
leukocyt
matur
plasma
cell
predomin
pbstreat
mice
three
l
gasseritr
group
show
diversif
colon
bcell
popul
compar
pb
control
fig
character
significantli
increas
percentag
b
cell
b
cell
transit
plasma
wildtyp
genet
modifi
l
gasseri
affect
reg
ratio
murin
colon
next
sought
determin
effect
l
gasseri
treatment
cell
popul
murin
colon
lymphocyt
isol
colon
three
consecut
day
bacteri
treatment
stain
cell
reveal
treatment
l
gasseri
significantli
increas
percentag
regulatori
cell
reg
murin
colon
compar
pb
treatment
alon
fig
contrast
treatment
genet
modifi
lactobacilli
significantli
decreas
reg
popul
colon
compar
wtand
pbstreat
mice
cell
identifi
intracellular
cytokin
stain
compar
pb
treatment
observ
statist
signific
decreas
cell
mice
treat
l
gasseri
contain
empti
express
plasmid
fig
treatment
wildtyp
l
gasseri
flicp
also
led
decreas
percentag
cell
decreas
signific
wildtyp
genet
modifi
l
gasseri
surviv
colon
intestin
tract
determin
optim
dose
live
oral
deliv
bacteriumbas
vaccin
must
consid
whether
bacteria
surviv
acid
environ
stomach
bile
proxim
small
intestin
whether
bacteria
colon
gastrointestin
tract
whether
host
mount
antivector
respons
upon
multipl
exposur
empir
assess
effect
dose
persist
balbc
mice
oral
gavag
l
gasseri
five
dose
cfu
h
quantiti
bacteria
found
fece
directli
relat
inocul
dose
fig
fecal
shed
continu
h
anim
receiv
cfu
l
gasseri
never
recov
cecum
small
intestin
larg
intestin
upon
cultur
intestin
tissu
lumin
content
necropsi
h
postinocul
data
shown
conclud
cfu
l
gasseri
optim
dose
mice
persist
h
readili
concentr
dose
oral
gavag
common
concern
vector
vaccin
induct
antivector
immun
respons
case
lactobacilli
may
reduc
efficaci
subsequ
boost
affect
vector
persist
also
could
result
anticommens
respons
associ
inflammatori
bowel
diseas
assess
likelihood
antil
gasseri
respons
inocul
mice
cfu
l
gasseri
interv
total
six
immun
although
variat
exist
time
point
within
inocul
group
net
increas
decreas
fecal
shed
control
recombin
l
gasseri
observ
time
fig
thu
multiboost
inocul
approach
alter
hostbacterium
interact
way
affect
magnitud
fecal
shed
persist
beyond
h
l
gasseri
vector
host
furthermor
detect
mucos
system
antibodi
bacteri
treatment
fig
suggest
immun
l
gasseri
vector
prompt
antivector
immun
respons
goal
studi
assess
key
immunomodulatori
characterist
wildtyp
recombin
l
gasseri
specif
aim
develop
lactobacillu
gasseri
oral
deliv
vaccin
vector
determin
tlr
activ
profil
l
gasseri
limit
heterodim
could
expand
includ
express
flic
fulli
character
activ
human
myeloid
dendrit
cell
recombin
wildtyp
l
gasseri
comprehens
assess
cytokin
chemokin
express
lastli
investig
immunomodulatori
effect
oral
administ
l
gasseri
colon
band
tcell
popul
taken
togeth
result
set
stage
gmcsf
shown
interact
dendrit
cell
dcsign
character
tlr
bind
activ
l
gasseri
demonstr
preferenti
activ
heterodim
lesser
activ
alon
given
lipoprotein
gramposit
bacteria
two
lipid
chain
togeth
form
diacyl
motif
known
essenti
dimer
surpris
l
gasseri
preferenti
activ
tolllik
receptor
heterodim
studi
report
effect
specif
activ
adjuv
mous
model
hsv
infect
vagin
pretreat
mice
ligand
produc
statist
signific
increas
product
treatment
macrophag
shown
increas
phagocytosi
bacteria
upregul
dcsign
treatment
dendrit
cell
induc
matur
net
effect
l
gasseri
tlr
activ
depend
cell
type
mucosa
express
heterodimer
partner
capac
l
gasseri
access
cell
type
consider
bodi
evid
shown
flagellin
potent
adjuv
vaccin
immunogen
potenti
lactobacillu
casei
express
flagellin
previous
report
mucosa
signal
promot
rapid
product
lead
data
show
oral
treatment
flicp
increas
cell
popul
murin
colon
fact
despit
statist
differ
percentag
among
treatment
group
percentag
quit
low
like
biolog
signific
express
extracellular
surfac
immun
cell
basolater
surfac
intestin
epitheli
cell
thu
intracellular
flagellin
express
flicp
may
avail
bind
vivo
condit
biolog
sequestr
flagellin
may
account
low
percentag
observ
compar
studi
involv
signal
cell
surfac
express
flic
could
increas
bind
uncertain
whether
surfaceexpress
flic
could
surviv
gastric
acid
bile
salt
transit
immun
induct
site
intestin
studi
involv
cell
surfaceassoci
flagellin
would
necessari
resolv
question
cytokineinduc
effect
mani
strain
lactobacilli
dc
report
typic
focu
cytokin
given
complex
mucos
immun
respons
chose
take
comprehens
look
cytokin
chemokin
express
human
myeloid
dendrit
cell
synthet
ligand
use
posit
control
l
gasseri
induc
broader
spectrum
greater
magnitud
cytokin
chemokin
express
alon
suggest
immunostimulatori
effect
l
gasseri
involv
activ
result
similar
report
zeuthen
et
al
studi
employ
l
acidophilu
cytokinechemokin
profil
induc
l
gasseri
gener
interpret
proinflammatori
notabl
except
low
express
concomit
increas
express
upregul
downregul
express
lactobacilli
report
mediat
conflict
result
due
lactobacillu
speci
use
cell
type
evalu
tempor
order
stimul
complic
complex
report
proinflammatori
antiinflammatori
pattern
recognit
receptor
howev
mohamadzadeh
et
al
clearli
show
although
oral
administr
adjuv
l
gasseri
result
high
ratio
net
effect
bacteri
treatment
signific
protect
b
anthraci
infect
although
rel
amount
often
cite
predictor
inflammatori
statu
result
mohamadezadeh
et
al
studi
suggest
ratio
reli
upon
alon
predict
vaccin
effect
thu
mix
inflammatori
profil
result
l
gasseri
treatment
deter
usag
l
gasseri
vector
cumul
effect
cytokin
milieu
need
studi
detail
determin
consequ
downstream
immun
respons
found
l
gasseri
surviv
passag
ho
grangett
et
al
show
lactic
acid
bacteri
strain
persist
gi
tract
less
effici
initi
protect
humor
immun
respons
host
bacteria
persist
gi
tract
howev
longterm
colon
recombin
l
gasseri
gastrointestin
tract
may
optim
sever
reason
first
may
unintend
consequ
recombin
l
gasseri
compet
potenti
alter
host
microbiom
addit
longterm
shed
genet
modifi
organ
unlik
achiev
regulatori
approv
lastli
colon
may
compat
immunogen
recent
studi
round
et
al
clearli
demonstr
commens
colon
depend
reg
induct
bacteria
wherea
case
reg
induct
like
would
fig
interact
genet
modifi
lactobacilli
host
balbc
mice
administ
l
gasseri
nck
via
oral
gavag
cfu
three
consecut
day
prior
euthanasia
cfu
per
g
fece
determin
h
rogosa
agar
supplement
erythromycin
gml
use
bacteri
select
b
balbc
mice
oral
gavag
bacteria
interv
total
five
boost
number
cfu
per
gram
fece
determin
h
dose
l
gasseri
coloni
detect
pbstreat
group
c
lactobacillusspecif
serum
igg
fecal
iga
measur
elisa
hyperimmun
mice
inocul
intranas
subcutan
oral
either
pb
nck
use
neg
posit
control
respect
n
anim
per
group
vol
assess
l
gasseri
oral
vaccin
vector
march
guest
http
cviasmorg
undermin
attempt
tip
balanc
toler
immun
induct
commens
vaccin
vector
interestingli
found
recombin
l
gasseri
significantli
reduc
percentag
reg
colon
lamina
propria
lead
clinic
gross
patholog
abnorm
induct
antilactobacillu
antibodi
respons
knowledg
previou
studi
report
effect
oral
lactobacillu
treatment
bcell
popul
murin
colon
studi
show
treatment
l
gasseri
significantli
increas
percentag
cell
yet
differenti
matur
plasma
cell
may
explain
associ
increas
mucos
iga
oral
l
gasseri
treatment
whether
l
gasseri
gener
flicp
particular
affect
magnitud
kinet
plasma
cell
induct
investig
use
techniqu
measur
absolut
number
cell
colon
lamina
propria
rather
simpli
percentag
strong
proofofprincipl
studi
perform
util
l
gasseri
vaccin
vector
mohamadzadeh
et
al
shown
dramat
protect
anthrax
challeng
mice
furthermor
excel
tool
exist
manipul
l
gasseri
express
vector
result
present
shed
new
light
basic
attribut
l
gasseri
interact
host
mucos
immun
system
understand
mechan
immun
modul
commens
l
gasseri
essenti
ration
develop
oral
vaccin
vector
